Sustained release of 5-fluorouracil from polymeric nanoparticles

被引:64
作者
McCarron, PA [1 ]
Woolfson, AD [1 ]
Keating, SM [1 ]
机构
[1] Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland
关键词
D O I
10.1211/0022357001777658
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The use of biodegradable nanoparticles loaded with 5-fluorouracil was investigated as a potential means to sustain the release of this drug. Nanoparticles prepared from four biodegradable polymers were loaded with 5-fluorouracil using three loading concentrations of drug and three different concentrations of added polymer. Washing particles using a centrifugation/re-suspension with ultrasound protocol was found to dislodge the majority of drug, resulting in an over-estimation of incorporation efficiency and low levels of strongly entrapped drug. Increasing the initial 5-fluorouracil concentration before polymer/monomer addition increased the drug loading in both washed and unwashed particles. Increasing the amount of polymer used to make nanoparticles did not increase loadings, but did produce increased amounts of unusable polymer waste. Drug release from nanoparticles was evaluated using a Franz cell diffusion apparatus, which showed an initial burst effect followed by a slower release phase over 24 h. Indeed, nanoparticles prepared from poly(lactide-co-glycolide) released 66% of their 5-fluorouracil payload over this period. It was concluded that 5-fluorouracil-loaded nanoparticles could be readily included into a hydrogel-based delivery system to provide sustained drug release for trans-epithelial drug-delivery applications.
引用
收藏
页码:1451 / 1459
页数:9
相关论文
共 22 条
[1]   5-fluorouracil-loaded chitosan microspheres: Preparation and release characteristics [J].
Akbuga, J ;
Bergisadi, N .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (02) :161-168
[2]  
COUVREUR P, 1988, CRIT REV THER DRUG, V5, P1
[3]  
COUVREUR P, 1995, EUR J PHARM BIOPHARM, V41, P2
[4]   ACTIVE TARGETING WITH PARTICULATE CARRIER SYSTEMS IN THE BLOOD COMPARTMENT [J].
CROMMELIN, DJA ;
SCHERPHOF, G ;
STORM, G .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 17 (01) :49-60
[5]  
DOUGLAS SJ, 1987, CRIT REV THER DRUG, V3, P233
[6]   NANOCAPSULE FORMATION BY INTERFACIAL POLYMER DEPOSITION FOLLOWING SOLVENT DISPLACEMENT [J].
FESSI, H ;
PUISIEUX, F ;
DEVISSAGUET, JP ;
AMMOURY, N ;
BENITA, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (01) :R1-R4
[7]   CALCULATIONS OF DRUG RELEASE RATES FROM SPHERICAL-PARTICLES [J].
GUY, RH ;
HADGRAFT, J ;
KELLAWAY, IW ;
TAYLOR, MJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1982, 11 (03) :199-207
[8]  
Heidelberger C, 1965, Prog Nucleic Acid Res Mol Biol, V4, P1, DOI 10.1016/S0079-6603(08)60783-7
[9]   EVALUATION OF CARRIER CAPACITY AND RELEASE CHARACTERISTICS FOR POLY(BUTYL 2-CYANOACRYLATE) NANOPARTICLES [J].
ILLUM, L ;
KHAN, MA ;
MAK, E ;
DAVIS, SS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 30 (01) :17-28
[10]   INTERFACIAL POLYMERIZATION, A USEFUL METHOD FOR THE PREPARATION OF POLYMETHYLCYANOACRYLATE NANOPARTICLES [J].
KRAUSE, HJ ;
SCHWARZ, A ;
ROHDEWALD, P .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (04) :527-552